Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?
出版年份 2010 全文链接
标题
Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?
作者
关键词
-
出版物
ANNALS OF ONCOLOGY
Volume 21, Issue 12, Pages 2324-2332
出版商
Oxford University Press (OUP)
发表日期
2010-05-25
DOI
10.1093/annonc/mdq204
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Immunotherapy for Lung Cancer
- (2010) Penelope A. Bradbury et al. Journal of Thoracic Oncology
- Alternating XELFOX and XELFIRI in Patients With Metastatic Colorectal Cancer
- (2009) Francesco Recchia et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- TheEML4-ALKfusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-typeEGFRandKRAS
- (2009) Daisy Wing-Sze Wong et al. CANCER
- Impact of Epidermal Growth Factor Receptor and KRAS Mutations on Clinical Outcomes in Previously Untreated Non-Small Cell Lung Cancer Patients: Results of an Online Tumor Registry of Clinical Trials
- (2009) D. M. Jackman et al. CLINICAL CANCER RESEARCH
- Emerging therapies in castrate-resistant prostate cancer
- (2009) Kiran Lassi et al. CURRENT OPINION IN ONCOLOGY
- Progression-Free Survival as a Predictor of Overall Survival in Men With Castrate-Resistant Prostate Cancer
- (2009) Susan Halabi et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of Sensitivity Analyses in Assessing Progression-Free Survival in Late-Stage Oncology Trials
- (2009) Suman Bhattacharya et al. JOURNAL OF CLINICAL ONCOLOGY
- Issues in Using Progression-Free Survival When Evaluating Oncology Products
- (2009) Thomas R. Fleming et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib Versus Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: Results From a Two-Part, Double-Blind, Randomized Phase II Study
- (2009) Ronald B. Natale et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
- (2009) Alice T. Shaw et al. JOURNAL OF CLINICAL ONCOLOGY
- Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
- (2009) Robert Pirker et al. LANCET
- Ixabepilone: targeting III-tubulin expression in taxane-resistant malignancies
- (2009) C. Dumontet et al. MOLECULAR CANCER THERAPEUTICS
- FDA Review of a Panitumumab (VectibixTM) Clinical Trial for First-Line Treatment of Metastatic Colorectal Cancer
- (2009) R. M. Giusti et al. ONCOLOGIST
- Vandetanib (ZD6474), a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor (VEGFR) and Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinases: Current Status and Future Directions
- (2009) A. Morabito et al. ONCOLOGIST
- Progression-free survival and time to progression as primary end points in advanced breast cancer: often used, sometimes loosely defined
- (2008) E. D. Saad et al. ANNALS OF ONCOLOGY
- Therapeutic Strategy for Treatment of Metastatic Non-Small Cell Lung Cancer
- (2008) Malik Berhoune et al. ANNALS OF PHARMACOTHERAPY
- A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses
- (2008) David Cameron et al. BREAST CANCER RESEARCH AND TREATMENT
- Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer
- (2008) B Sherrill et al. BRITISH JOURNAL OF CANCER
- Multicentric, Randomized Phase III Trial of Two Different Adjuvant Chemotherapy Regimens plus Three Versus Twelve Months of Trastuzumab in Patients with HER2-Positive Breast Cancer (Short-HER Trial; NCT00629278)
- (2008) Valentina Guarneri et al. Clinical Breast Cancer
- Management of Unresectable Stage III Non–Small-Cell Lung Cancer with Combined-Modality Therapy: A Review of the Current Literature and Recommendations for Treatment
- (2008) Neil A. Bayman et al. Clinical Lung Cancer
- Bevacizumab in Non-Small Cell Lung Cancer
- (2008) Francesco Di Costanzo et al. DRUGS
- Raltitrexed (Tomudex®) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1)
- (2008) Ivan Popov et al. EUROPEAN JOURNAL OF CANCER
- Evaluation of lymph nodes with RECIST 1.1
- (2008) L.H. Schwartz et al. EUROPEAN JOURNAL OF CANCER
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Vinflunine: clinical perspectives of an emerging anticancer agent
- (2008) Adrian Yun-San Yip et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Bevacizumab for the treatment of advanced non-small-cell lung cancer
- (2008) Christian Manegold Expert Review of Anticancer Therapy
- Docetaxel in the treatment of advanced non-small-cell lung cancer
- (2008) Emmanouel Saloustros et al. Expert Review of Anticancer Therapy
- Gene expression profiling of non-small-cell lung cancer
- (2008) Ludovic Lacroix et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Progression-free survival as a surrogate endpoint in advanced breast cancer
- (2008) Rebecca A. Miksad et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Cetuximab Plus Irinotecan in Heavily Pretreated Metastatic Colorectal Cancer Progressing on Irinotecan: MABEL Study
- (2008) Hansjochen Wilke et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of Tumor Response, Disease Control, Progression-Free Survival, and Time to Progression As Potential Surrogate End Points in Metastatic Breast Cancer
- (2008) Tomasz Burzykowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study Comparing Exemestane With Tamoxifen As First-Line Hormonal Treatment of Metastatic Breast Cancer in Postmenopausal Women: The European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group
- (2008) Robert J. Paridaens et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter, Phase II Trial of Sunitinib in Previously Treated, Advanced Non–Small-Cell Lung Cancer
- (2008) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III, Double-Blind, Randomized Study Comparing Lapatinib Plus Paclitaxel With Placebo Plus Paclitaxel As First-Line Treatment for Metastatic Breast Cancer
- (2008) Angelo Di Leo et al. JOURNAL OF CLINICAL ONCOLOGY
- Biological Agents in Non-small Cell Lung Cancer: A Review of Recent Advances and Clinical Results with a Focus on Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor
- (2008) Karen Kelly et al. Journal of Thoracic Oncology
- Targeting Angiogenesis in the Treatment of Lung Cancer
- (2008) Paul Wheatley-Price et al. Journal of Thoracic Oncology
- Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
- (2008) Edward S Kim et al. LANCET
- Lung Cancer
- (2008) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab and Erlotinib: A Promising New Approach to the Treatment of Advanced NSCLC
- (2008) R. S. Herbst et al. ONCOLOGIST
- Systemic Chemotherapy for Advanced Non-Small Cell Lung Cancer: Recent Advances and Future Directions
- (2008) S. Ramalingam et al. ONCOLOGIST
- Targeted Therapy in Advanced Non-Small-Cell Lung Cancer
- (2008) Scott Gettinger SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Individual- and trial-level surrogacy in colorectal cancer
- (2008) Marc Buyse et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Neoadjuvant Therapy for Resectable Non–Small Cell Lung Cancer with Mediastinal Lymph Node Involvement
- (2008) Brandon H. Tieu et al. Thoracic Surgery Clinics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started